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Toxicity and antioxidant capacity of eugenol derivatives (E2 = 2-Methoxy-4-[1-propenylphenyl]acetate, E3 = 4-Allyl-2-
methoxyphenylacetate, E4 = 4-Allyl-2-methoxy-4-nitrophenol, E5 = 5-Allyl-3-nitrobenzene-1,2-diol, E6 = 4-Allyl-2-methoxy-5-
nitrophenyl acetate) were evaluated in order to determine the influence of the sustituents. E2-E6 were synthesized from eugenol (E1). 
E1 was extracted from cloves oil, and E2-E6 were obtained through acetylation and nitration reactions. Antioxidant capacity evaluated 
by DPPH (1, 1-Diphenyl-2-picrylhydrazil) and ORAC fluorescein demonstrated that E1 and E5 have a higher capacity and the minor 
toxicity evaluated by red blood cells haemolysis and the Artemia saline test. In accordance with our results, the compound’s (E1-E5) 
use in the pharmaceutical, cosmetic and or food industries could be suggested. 
Keywords: eugenol derivatives; antioxidant capacity.
INTRODUCTION
Phenols, specially fl avonoids and antocians show a great capac-
ity to scavenge free radicals that causes the oxidative stress.1-4 They 
have anti-inflammatory, antiallergic, antitrombotic, antimicrobial and 
antineoplasic activity.5-8 
The eugenol (E1) is a phenolic derivative commonly known as 
nail essence9 that can also be extracted from pepper, bay leaves, 
cinnamon, nutmeg, camphor and some natural oils.10 E1 is a yel-
low oily liquid with a characteristic fragrance which is soluble in 
alcohol and presents a low solubility in water.9 Several studies have 
demonstrated the antioxidant capacity of the eugenol and related 
compounds (like isoeugenol) to inhibit the lipidic peroxidation in-
duced by reactive oxygen species.11,12 It also inhibits the superoxide 
radical formation in the xanthine-xanthine oxidase system.13 E1 can 
inhibit the hydroxyl radical generation, and can prevent the Fe2+ 
oxidation in the Fenton reaction that generates the radical. This is 
one of the most aggressive radicals for the human tissue.14 In high 
concentrations it has a bactericidal effect that has been attributed 
to phenol groups: by degeneration of proteins can damage the cel-
lular membrane, however, at low concentrations it tends to stabilize 
cellular membranes. The pharmacologic effects of the eugenol are 
complex and depend on the free eugenol concentration to which 
the human tissue is exposed.15
The aim of this study was to evaluate the antioxidant and toxicolo-
gist properties of these pure derivatives (Figure 1) as a contribution 
to possible future applications. 
EXPERIMENTAL
Synthesis of eugenol’s derivatives 
Eugenol (E1) was obtained from cloves smell, according to 
standard procedure.16
4-allyl-2-methoxy-6-nitrophenol (E4) and 5- allyl -�-nitro�en-
zene-1, 2-diol (E5) 17
Eugenol 1.5 g (9.15 mmol) was dissolved in dichloromethane
 
(30 
mL) and was added to a mixture stirred which contained 4.5 g (33 
mmol) of potassium hydrogen sulphate, 3.0 g (35.3 mmol) of sodium 
nitrate and 3.5 g of wet silica to 50% P/P; the mixture was left to 
continue at room temperature for 5.5 h. The complete disappearance 
of the starting product was confirmed by means of the thin layer 
chromatography (TLC) method (ethyl acetate: n-hexane 1:3). The 
reacted mixture was filtered through silica and the solid was washed 
with dichloromethane, and the solvent evaporated in vacuum to give 
reddish oil. Pure product was obtained by CC (5:1-3:1 ethyl acetate 
in hexane), which gave 1.10 g of the desired compound E4 (63.2% 
yield) and 0.043 g (2.9%) of E5.
Figure 1. Structures of eugenol derivatives
Hidalgo et al.1468 Quim. Nova
4-allyl-2-methoxyphenyl acetate (E3) 17
To a stirred solution of eugenol 10.00 g (6.10 mmol) in pyridine 
(2.00 mL) was added dichloromethane (20 mL) and 10 mg of 4-N,N-
dimethylaminopyridine (DMAP). The solution was stirred at room 
temperature for 30 min. Acetic anhydride was added and the reaction 
was left to continue for 1 h and after this period, the complete disa-
ppearance of the starting product was confirmed by means of the thin 
layer chromatography (TLC) method (ethyl acetate: n-hexane 1:3).
To the stopped reaction a 10% solution of potassium hydrogen 
sulphate was added and extracted with dichloromethane. The organic 
phase was washed with water (3 x 20 mL) until pH 7, dried with 
anhydrous Na2SO4 and vacuum evaporated. Pure product was obtained 
by column chromatography (5:1-3:1 ethyl acetate in hexane), which 
gave the desired compound with quantitative yield. 
4-allyl-2-methoxy-5-nitrophenyl acetate (E6) 17
To a stirred solution of 4-allyl-2-methoxyphenyl acetate 200 mg 
(0.97 mmol) in dichloromethane (5 mL) was carefully added at 
0 °C 2 mL of a sulphonitric mixture, which was prepared by adding 
concentrated nitric acid on concentrated sulphuric acid. The reaction 
was left to continue for 30 min and after this period, the complete disa-
ppearance of the starting product was confirmed by means of the thin 
layer chromatography (TLC) method (ethyl acetate: n-hexane 1:3). 
The reaction stops by adding 15 mL water. The organic layer was 
washed with water (3 x 20 mL) in order to extract the excess of acid 
present and dried with anhydrous Na2SO4, filtered, and the solvent was 
evaporated at low pressure obtaining an oily product, which was puri-
fied by Flash Chromatography (ethyl acetate: n-hexane) which allowed 
obtaining 89 mg (35%) of the mixture of pure isomers, then the mixture 
of isomers was re-crystallized from a of ethyl acetate/n-hexane mixture.
2-methoxy-4-(prop-1-enyl) phenyl acetate (E2)
To a stirred solution of (E)-2-methoxy-4-(prop-1-enyl) phenol 
(isoeugenol) 10.00 g (0.061 mol) in pyridine (2.00 mL) was added 
dichloromethane (20 mL) and 10 mg of 4-N,N-dimethylaminopyrid-
ine (DMAP). The solution was stirred at room temperature for 30 min. 
Acetic anhydride was added and the reaction was left to continue for 
1 h and after this period, the complete disappearance of the starting 
product was confirmed by means of the thin layer chromatography 
(TLC) method (ethyl acetate: n-hexane 1:3).
To the stopped reaction a 10% solution of potassium hydrogen 
sulphate was added and extracted with dichloromethane. The organic 
phase was washed with water (3 x 20 mL) until pH 7, dried with an-
hydrous Na2SO4 and vacuum evaporated. Pure product was obtained 
by column chromatography (5:1-3:1 ethyl acetate in hexane), which 
gave the desired compound with quantitative yield. 
ORAC Assay
The sample (20 µL), in phosphate buffer (5 µL, 75 mM, pH 
7.4), and main reagent (365 µL FL, 48 nM) were mixed and incu-
bated for 30 s before recording the initial fluorescence (f0), FL and 
2,2’-azobis(2-aminopropane)dihydrochloride (AAPH) were prepared 
with 75 mM phosphate buffer at pH 7.4. Fluorescence readings were 
taken at 0.5 s and then every minute thereafter (f1, f2, f3, ...) during 
30 min. The final ORAC values were calculated using a regression 
equation between the Trolox concentration and the net area under 
the FL decay curve, and were expressed as Trolox equivalents as 
micromole per liter or per gram. The area under curve (AUC) was 
calculated as: AUC = 1+ f1/f0 + f2/f0 + f3/f0 + f4/f0 + ... + f34/f0 + 
f35/f0 where f0 is the initial fluorescence reading at 0 min and fi is 
the fluorescence reading at time i. The resulting AUC was obtained 
by subtracting the AUC of the blank from that of the sample. The 
relative ORAC value (Trolox equivalents) was calculated as: 18
[(AUCSample- AUCBlank)/(AUCTrolox- AUCBlank) x (mola-
rity of Trolox/molarity of sample)]
DPPH
The antiradical activities of various antioxidants were determined 
using the free radical, 1,1-Diphenyl-2-picrylhydrazyl (DPPH). In its 
radical form, DPPH has an absorption band at 515 nm which disap-
pears upon reduction by an antiradical compound.19 
Toxicity test: Eggs from Artemia saline 
(Class: Crustacea, Subclass: branchiopoda; Super order: anos-
traca, Family: artemidae, Genus: artemia). The cysts of Artemia 
saline were incubated in filtered sea water (micropore 0.22 µm) and 
oxygenated during 45 min at 30 ˚C temperature in a thermo regulate 
bath and fit to pH 8 in NaOH 0.1 M. After 24 h, the eclosionated 
nauplius (first stage of the Artemia saline) are in conditions for the 
accomplishment of the toxicity tests.20 
Toxicity in red cell model
Red blood cells of healthy adult donors were used. Shortly 
after collection, the heparinised blood was centrifuged at 2,000 g 
and both the plasma and buffy coat discarded. The remaining red 
cells were washed three times with an isotonic solution (0.15 M 
NaCl on 0.01 M sodium phosphate (PBS), pH 7.4). The red cells 
were resuspended to approximately 2% v/v, kept at 6 ºC and used 
in the next 72 h. The percentage of haemolysis was determined 
immediately after irradiation by measuring the haemoglobin 
liberated in the medium from solutions containing 0.4% red 
cells. Measurements were carried out at 540, 560, 577, 630 and 
700 nm, and the concentrations were evaluated according to the 





These phenolic compounds (Figure 1) present hydroxyl groups 
in their aromatic ring that exert their antioxidant properties. The 
antioxidant potential of each derivative was determined by means 
of the quenching rate constant (k) for the fluorescence decay. The 
ORAC values (Table 1) showed a significant difference between 
E1 and E5 compared to the other compounds. This demonstrates 
the antioxidant properties of these derivatives, caused by the 
presence of phenolic groups in the aromatic ring which form a 
phenolic radical. This radical, which would become stabilized by 
resonance with the double bonds of the aromatic ring, allows the 
formation of radicals in two positions: ortho (o) and para (p) of 
Table 1. ORAC-FL values (100 µM) derivatives
Derivative Value ORAC-FL SD
E1 1.9854 ±   1.1*10-3
E2 1.8619 ±   5.4*10-3
E3 1.9057 ±   5.7*10-3
E4 1.9622 ±   3.6*10-3
E5 2.0727 ±   3.2*10-2
E6 1.6998 ±   1.5*10-3
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the aromatic ring from the phenolic group (Figure 2). E1 and E5 
present the highest number of resonance structures, contributing 
to the stability of the phenolic radical. E1-E5 present sustituents 
with inductive effect -I (electron-attractive), such as the methoxy 
group and the nitro group that tends to destabilize the phenolic 
radical (Figure 3).
Between both effects (inductive effect and resonance), the 
resonance presents a greater importance in the stability of the radi-
cal. Similarly, E4 is the phenolic derivative that presents the minor 
antioxidant effect, possibly due to the presence of the nitro group 
that allows the formation of interactions between the hydrogen and 
the OH radical, which would prevent the formation of the phenolic 
radical (Figure 3). 
According to Figure 4 by DPPH method, E1 and E5 derivatives 
cause a significant reduction of absorbance. The derivatives E1 and 
E4 present a methoxyl group (electron donor for resonant effect) 
in ortho (o) with respect to OH group, which allows to stabilize 
the phenolic radical, contributing to the formation and stability of 
the radical (Figure 2a). E2-E3-E6 present low quenching constant 
values, indicating small antioxidant capacity caused, probably, due 
to low probability of allyl radicals’ formation, which could become 
stabilized by resonance with the aromatic ring or the double bonds 
(Figure 2b). E2-E3-E6 have substituent with inductive effect -I 
(electron-attractive), as the acetate, methoxyl and nitro groups, 
which tend to destabilize the formation of an allyl radical, but 
due to the distance with respect to the allyl radical, their effect is 
insignificant. 
The toxicity results in the red cell model provided information 
about the haemolysis caused by the eugenol derivatives in the plas-
matic membrane of the erythrocyte (Table 2). 
The values obtained are lower than 1%, which indicate that 
in general they are not toxic since the haemolysis percentage is 
comparable to the mechanical damage caused by manipulating 
the blood. By the lack of knowledge of the derivative plasmatic 
concentration that these derivatives could reach, a concentration 
of 25.25 µM was considered, which is 1000 times higher to the 
plasmatic concentration of the reference compound 3,4-methy-
lendioxymetamfetamine (MDMA) that was chosen considering 
its structural similarity with the derivatives in study, therefore, 
they are slightly toxic or its toxicity is insignificant with respect 
to other types of damage that undergoes the erythrocyte. The re-
sults obtained in the bioassay with Artemia saline, indicate that 
E5 (5-allyl-3-nitrobenzene-1,2-diol) is the derivative that presents 
highest LD50 (89.1 ± 32.2), which means it requires a higher con-
centration to cause a significant effect in comparison to E3 that 
presented the lowest LD50 (16.2 ± 3.82) , resulting to be the most 
toxic of the eugenol derivatives, possibly due to the presence of 
the acetate and methoxy group (Table 3).
A concordance between the results from both antioxidant tests 
was observed, demonstrating that E1 and E5 are those that present 
higher antioxidant capacity.
E5 is the less toxic eugenol derivative according to both methods 
used. The eugenol derivatives, in red blood cells model, have toxicity 
lower than 1% (toxicity), thus are only slightly toxic against the 
erythrocyte membrane.
Figure 2. a) Radical formation in phenol derivatives E1 and E4, �) allyl 
radical formation in acetate derivatives
Figure 3. Nitro and methoxy effect
Figure 4. Consumption rate constant (k) determination from radical a�sorp-
tion (100 µM) at 517 nm. (DPPH method)
Table 2. Hemolysis percentage for eugenol derivatives
Hemolysis percentage
Concentration ppm E1 E2 E3 E4 E5 E6
1 0.36 0.37 0.33 0.34 0.32 0.34
10 0.53 0.44 0.55 0.43 0.39 0.48
25.25 0.58 0.52 0.61 0.51 0.42 0.55
100 0.73 0.72 0.74 0.69 0.51 0.72
Table 3. LD50 values for eugenol derivatives
LD50 x² Confidence limit
17.8 1.68 ± 3.77
31.6 1.48 ± 5.72
16.2 1.70 ± 3.82
40.7 0.85 ± 9.14
89.1 0.20 ± 32.2
31.6 1.18 ± 6.74
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CONCLUSIONS
 
The results of both antioxidant assays demonstrated that E1 and E5 
have the greatest capacity as free radical scavengers, due to the presence 
of one or more phenolic groups in the aromatic ring, which are essential 
for its antioxidant capacity. E5 has the lowest toxicity, nevertheless 
eugenol’s derivatives exhibited a haemolysis percentage lower than 1%, 
which is a very low toxicity level for the red cell membranes.
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